Free Trial

IM Cannabis Q4 2023 Earnings Report

IM Cannabis logo
$2.08 +0.08 (+4.00%)
(As of 12/20/2024 05:31 PM ET)

IM Cannabis EPS Results

Actual EPS
-$1.08
Consensus EPS
-$0.96
Beat/Miss
Missed by -$0.12
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$7.86 million
Expected Revenue
$7.59 million
Beat/Miss
Beat by +$270.00 thousand
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

First JFK… next Elon? (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

IM Cannabis Earnings Headlines

IM Cannabis Corp Raises Funds Amid Global Challenges
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
IM Cannabis Reports Third Quarter Financial Results
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings